Trial intelligence / Profile preview

Lurasidone vs Olanzapine in First Episode Schizophrenia

NCT03304457Phase 4Completed

Sponsor
AIIMS New Delhi
Start
Aug 2017
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lurasidone in schizophrenia, sponsored by AIIMS New Delhi. Started Aug 2017; status: completed.

02

Drugs

lurasidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT03304457.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03304457.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call